CDC- BRFSS – ACBS 2024 Adult Prevalence Table 7

Print
Related Pages
Table 7: Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2024.
State/Territory Current
Sample
size±		 % SE§ 95% CI†
Arizona 328 19.6 3.5 (12.7 – 26.5)
California 273 26.1 4.1 (18.1 – 34.1)
Connecticut 301 21.6 2.8 (16.1 – 27.1)
Florida 365 21.9 4.0 (14.1 – 29.7)
Georgia 324 20.7 3.0 (14.8 – 26.6)
Illinois 344 29.8 3.0 (23.9 – 35.7)
Indiana 573 25.8 2.1 (21.7 – 29.9)
Iowa 265 28.1 3.6 (21.0 – 35.2)
Kansas 312 27.3 3.3 (20.8 – 33.8)
Kentucky 146 27.5 4.7 (18.3 – 36.7)
Maine 412 28.2 3.0 (22.3 – 34.1)
Maryland 639 24.1 2.4 (19.4 – 28.8)
Massachusetts 355 34.8 3.3 (28.3 – 41.3)
Michigan 502 27.9 3.1 (21.8 – 34.0)
Minnesota 655 27.4 2.1 (23.3 – 31.5)
Missouri 171 33.8 5.7 (22.6 – 45.0)
Nebraska 326 25.0 3.6 (17.9 – 32.1)
New Hampshire 333 21.1 2.9 (15.4 – 26.8)
New Jersey 380 25.9 3.0 (20.0 – 31.8)
New York 821 23.7 2.2 (19.4 – 28.0)
Ohio 371 33.9 3.6 (26.8 – 41.0)
Oregon 201 25.6 3.6 (18.5 – 32.7)
Rhode Island 239 28.2 4.2 (20.0 – 36.4)
Texas 219 25.0 4.3 (16.6 – 33.4)
Utah 484 23.3 2.4 (18.6 – 28.0)
Vermont 310 33.8 3.6 (26.7 – 40.9)
Wisconsin 425 24.2 2.7 (18.9 – 29.5)
Puerto Rico 222 13.9 2.6 (8.8 – 19.0)
28 States / Area 10,296 26.0 0.9 (24.2 – 27.8)
Median 25.9
Range 13.9-34.8

 

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size for adults with current asthma, excludes “DK/Refused”

§ Standard error

† Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2024/pdf/sdq_report_acbs_24-508.pdf